Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
March 31, 2008
- GENERICS NEWS IN BRIEF
March 31, 2008
- OPINION／The Scuttlebutt on Pharma Takeovers
March 31, 2008
- 78 Generics of Amlodipine from 38 Companies Approved
March 31, 2008
- PET Facility Goes Bankrupt
March 31, 2008
- 16 APIs See Approval of 1st Generics
March 31, 2008
- 2 Former Company Employees Assigned to PMDA's Review Division within 2 Years of Employment
March 31, 2008
- Competitors' Exodus Gives Better Chance to NBI: Dr Nishikawa
March 24, 2008
- US Embassy, ACCJ Seminar Highlights Importance of Prevention
March 24, 2008
- Towa, Nichi-Iko to Hire More New Graduates
March 24, 2008
- Eisai Obtains Option Rights to M's Science's SA4503
March 24, 2008
- Pharmacists Are More Conservative than Doctors about the Use of Generics: CareNet Survey
March 24, 2008
- Sanofi-aventis to Enter Top-10 Club by Doubling Sales: Mr Fauchet
March 24, 2008
- Torrent Withdraws from Japan
March 24, 2008
- REGULATORY NEWS IN BRIEF
March 24, 2008
- Suzuken Renovates Customer Support Services Anticipating Increases in Demand for Generics
March 24, 2008
- Single-Tablet Combination of Galvus and Metformin Approved in EU: Novartis
March 24, 2008
- Nichi-Iko to Become Japan's No. 1 Generic Maker by Acquiring Teikoku Medix
March 24, 2008
- R&D NEWS IN BRIEF
March 24, 2008
- TOPICS 2 articles
March 24, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…